Coal tar
This article was originally published in The Tan Sheet
Executive Summary
Animal data on carcinogenic risk of dandruff shampoo ingredient insufficient to support a change in OTC monograph status or new labeling warnings, J&J subsidiary Neutrogena asserts in recent comments to FDA. Stressing its opposition to restrictions on coal tar-containing OTCs requested by Occupational Knowledge International (OKI) in a March petition, the T/Gel marketer also notes the research cited by the petitioners examined "coal tar oil, not coal tar" (1"The Tan Sheet" April 3, In Brief). Neutrogena is one of several defendants in the Prop 65 lawsuit over coal tar in OTCs brought by OKI and California Attorney General Bill Lockyer
Animal data on carcinogenic risk of dandruff shampoo ingredient insufficient to support a change in OTC monograph status or new labeling warnings, J&J subsidiary Neutrogena asserts in recent comments to FDA. Stressing its opposition to restrictions on coal tar-containing OTCs requested by Occupational Knowledge International (OKI) in a March petition, the T/Gel marketer also notes the research cited by the petitioners examined "coal tar oil, not coal tar" (1 (Also see "Coal tar safety" - Pink Sheet, 3 Apr, 2000.)). Neutrogena is one of several defendants in the Prop 65 lawsuit over coal tar in OTCs brought by OKI and California Attorney General Bill Lockyer. |